D-0605-2017 Class II Terminated
FDA drug recall D-0605-2017 was initiated by Zydus Pharmaceuticals USA Inc on Mar 6, 2017 and is designated Class II. Reason for recall: Presence of Foreign Tablets/Capsules: Customer complaint that a bottle of atenolol 50 mg Tablets USP contained a paroxetine 20 mg tablet. The recall status is terminated (terminated Nov 5, 2019). Affected quantity: 9561 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 29, 2017
- Initiation Date
- Mar 6, 2017
- Termination Date
- Nov 5, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 9561 bottles
Product description
ATENOLOL Tablets, USP, 50 mg, packaged in a) 100-count bottles (NDC 68382-023-01) and b) 1000-count bottles (NDC 68382-023-10), Rx only, Manufactured by: Cadila Healthcare Ltd., India; Distributed by: Zydus Pharmaceuticals USA Inc., Pennington, NJ 08534.
Reason for recall
Presence of Foreign Tablets/Capsules: Customer complaint that a bottle of atenolol 50 mg Tablets USP contained a paroxetine 20 mg tablet.
Distribution pattern
Nationwide in the USA and Puerto Rico.
Code information
Lot #: a) Z600724, Exp 04/18; Z600725, Exp 04/18
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0605-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026